Akebia Therapeutics AKBA

$ 1.87 2.47%

Quarterly report 2024-Q3
added 11-07-2024

Akebia Therapeutics EV/EBITDA Ratio 2011-2024 | AKBA

Annual EV/EBITDA Ratio Akebia Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-2.4	-1.03	-3.31	-3.29	-7.35	-1.34	-2.35	-3.31	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-1.03	-7.35	-3.05